This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Queenan, A. M.
Right arrow Articles by Bush, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Queenan, A. M.
Right arrow Articles by Bush, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2001, p. 3189-3194, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3189-3194.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Cloning and Biochemical Characterization of FOX-5, an AmpC-Type Plasmid-Encoded beta -Lactamase from a New York City Klebsiella pneumoniae Clinical Isolate

Anne Marie Queenan,*,1 Stephen Jenkins,2,dagger and Karen Bush1

The R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869,1 and The Mount Sinai Hospital, New York, New York 100292

Received 9 March 2001/Returned for modification 18 May 2001/Accepted 21 August 2001


    ABSTRACT
Top
Abstract
Text
References

Klebsiella pneumoniae 5064, isolated in New York, carried plasmid-mediated resistance to multiple beta -lactams and was unresponsive to clavulanic acid. The beta -lactamase gene responsible for cephalosporin resistance encoded FOX-5, with 96 to 97% amino acid identities to other members of the FOX family of beta -lactamases. The blaFOX-5 coding region was located next to a transposase gene from the Aeromonas salmonicida insertion element ISAS2.


    TEXT
Top
Abstract
Text
References

AmpC beta -lactamases in functional group 1 are characterized by their hydrolysis of cephalosporins and resistance to clavulanic acid inhibition (6). These beta -lactamases were originally described as chromosomal, inducible enzymes in the Enterobacteriaceae, with clinically problematic cephalosporin resistance occurring by stable derepression of the chromosomal ampC gene (15). In the late 1980s, ceftazidime resistance caused by a plasmid-borne AmpC enzyme was discovered in a Klebsiella pneumoniae clinical isolate (20). Since this time, there have been increasing reports of plasmid-encoded AmpC enzymes throughout the world (1, 5, 10, 13, 19, 23).

The FOX family of AmpC-type beta -lactamases has 76% amino acid homology to the Aeromonas sobria beta -lactamase CepS (24) and 72% homology to the K. pneumoniae CMY-1 AmpC enzyme (2). FOX-1 was discovered in a K. pneumoniae isolate from Argentina, and FOX-2 was identified in an E. coli strain from Guatemala (3, 11). Two additional members of the FOX family were recently isolated in Italy and Spain (4, 16). In the United States, K. pneumoniae and Escherichia coli strains producing FOX-type beta -lactamases in isolates from several southern states have been described (G. Jacoby, J. Tran, and M. Alvarez, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1481, 1999; N. D. Hanson, P. Coudron, E. S. Moland, C. C. Sanders, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1481, 1999).

In this paper, we present the sequence and biochemical characterization of FOX-5, a plasmid-borne AmpC enzyme that was identified in a K. pneumoniae isolate from The Mount Sinai Hospital of New York City.

(This work has been presented in part previously [A. M. Queenan, K. Bush, and S. Jenkins, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1470, 2000].)

K. pneumoniae 5064 was a urine culture isolate from a 90-year-old female nursing-home patient (Table 1). The MICs shown in Table 2 were determined by the NCCLS broth microdilution method (18). K. pneumoniae 5064 was resistant to penicillins and cephalosporins, including cephamycins, and refractory to inhibition by clavulanic acid. This clinical isolate was susceptible to imipenem, aztreonam, and gentamicin, intermediate to tetracycline, and resistant to ciprofloxacin and trimethoprim-sulfamethoxazole (Vitek Biomerieux, Durham, N.C.). K. pneumoniae 5064 contained a plasmid of approximately 125 kb, which was isolated with the Qiagen Miniprep kit, electroporated into E. coli DH5-alpha , and selected on Luria-Bertani agar containing 2 µg of ceftazidime per ml. The beta -lactam resistance profile of the E. coli DH5-alpha /p5064 transformant was similar to that of the clinical isolate, but ciprofloxacin, trimethoprim-sulfamethoxazole, and tetracycline resistance were not transferred with this plasmid.

beta -lactamases in K. pneumoniae 5064 and the E. coli transformant were examined by isoelectric focusing (IEF) of freeze-thaw lysates (7, 17) separated on Ampholine PAGplates (pH 3.5 to 9.5; Amersham Pharmacia, Piscataway, N.J.), with visualization using nitrocefin. To test inhibition, filter paper saturated with a single inhibitor (10 µg of aztreonam per ml, 100 µM tazobactam, or 50 mM EDTA) was applied to the IEF gel for 10 min before development with nitrocefin. IEF analysis revealed that K. pneumoniae 5064 contained three beta -lactamases, with pI values of 5.6, 7.2, and 7.6 (Table 1). The E. coli transformant carried the pI 5.6 and pI 7.2 enzymes. The enzymes with pI values of 5.6 and 7.6 were inhibited by tazobactam, consistent with TEM-2-like and SHV-type beta -lactamases. The beta -lactamase with pI 7.2 was inhibited by aztreonam but not by tazobactam or EDTA.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Bacterial strains

The isoelectric point and inhibition profile data of the pI 7.2 enzyme suggested an AmpC beta -lactamase, possibly of the FOX family. PCR of DNA from K. pneumoniae 5064 with FOX-specific primers FOX1F and FOX1H produced a band of approximately 1 kb, which was predicted to encompass the entire FOX-coding region (3). The PCR product was cloned into pCR2.1 (Invitrogen, Carlsbad, Calif.), and 13 clones were sequenced with M13rev and T7 primers by ACGT, Inc. (Northbrook, Ill.). The amino acid sequence and comparison to other members of the FOX family are shown in Fig. 1. The FOX-5 beta -lactamase was similar to all members of the FOX family, with amino acid identities of 96.1% to FOX-4, 96.6% to FOX-1 and FOX-3, and 96.9% to FOX-2.


View larger version (34K):
[in this window]
[in a new window]
  		FIG. 1.   Alignment of FOX-1 through FOX-5 deduced protein sequences, containing 382 amino acids. Bold type indicates the conserved elements for the serine beta -lactamases. The underlined serine corresponds to amino acid position 80 for E. coli AmpC in the work of Jaurin and Grundström (14).

A subclone of the FOX-5 region of p5064 was obtained by ligating EagI fragments of p5064 into pACYC184 cut by EagI (New England BioLabs, Beverly, Mass.) to yield pFOX-5. Transformants selected on agar containing 2 µg of ceftazidime per ml contained a single pI 7.2 beta -lactamase and displayed a beta -lactam resistance profile similar to that of K. pneumoniae 5064, except for the tazobactam-inhibited piperacillin resistance, which was probably contributed by the pI 5.6 TEM-2-type beta -lactamase on the original plasmid (Tables 1 and 2). The nucleotide sequence of the p5064 fragment containing blaFOX-5 is shown in Fig. 2. The transcriptional start site was mapped by primer extension (Promega, Madison, Wis.), and putative -10 and -35 sequences are underlined (21). Immediately 5' to the blaFOX-5 gene is a region with 98% DNA homology to the ISAS2 insertion element transposase from Aeromonas salmonicida (12), a member of the IS30 family. The DNA sequence downstream from the FOX-5 coding region contains an imperfect inverted repeat of 27 bp, followed by a CTG, two other features of ISAS2. These results suggest that the blaFOX-5 gene is part of an insertion sequence element. CMY-4 and several CTX-M beta -lactamases are also reported to be associated with insertion elements (P. D. Stapleton, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1457, 1999; GenBank AF286192 and GenBank AF252622).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   MICs of antimicrobial agents for K. pneumoniae 5064 and E. coli transformants




View larger version (101K):
[in this window]
[in a new window]
  		FIG. 2.   Nucleotide and deduced amino acid sequence for the p5064 FOX-5 region. Nucleotides 1 to 520 correspond to the sequence of the ISAS2 transposase, which is shown in italic type. Bold type indicates the transposase nucleotide and amino acid differences from the data reported by Gustafson et al. The FOX-5 transcription start is marked with an arrow, and putative -10 and -35 regions are underlined. The sequence used for the primer extension experiment is underlined. The FOX-5 putative ribosome-binding site is double underlined. The sequence downstream of the FOX-5 translational stop is from a second FOX-5 clone that extended past the EagI site. Elements of ISAS2, i.e., the imperfect inverted repeat and CTG, are underlined and bold, respectively (12).

The FOX-5 beta -lactamase was purified from the DH5-alpha /pFOX-5 transformant grown in tryptic soy broth with 2 µg of ceftazidime per ml. A freeze-thaw lysate (7) was passed through a Sephadex S-75 column in 50 mM phosphate buffer (pH 7.0). Active fractions were further purified using cation exchange in 25 mM phosphate buffer (pH 6.2) through HiTrap S (Amersham-Pharmacia), followed by anion exchange through HiTrap Q (Amersham-Pharmacia) in 25 mM Tris (pH 8.5). FOX-5 purity (98%) was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels stained with Coomassie blue; the molecular mass calculated from the gel was 37 kDa.

Hydrolysis data were obtained by measuring initial rates at 25°C on a Shimadzu 1600UV spectrophotometer (22). All substrates were prepared fresh in 50 mM phosphate buffer, pH 7.0. Km and Vmax were determined by averaging results of Eadie-Hofstee, Hanes, Cornish Bowden direct linear plots and a least-squares fit to the Michaelis-Menten equation. The concentration of inhibitor that decreased enzymatic activity by 50% (IC50) was determined by graphing percent control activity against concentration of inhibitor, using initial rates obtained after a 5-min preincubation of enzyme and inhibitor at 25°C. Cephaloridine at 100 µM was used as the substrate for the IC50 studies. The Ki of aztreonam was determined under steady-state conditions using the Dixon plot for inhibitors of high affinity, with cephaloridine as a substrate at 100 and 300 µM (9).

FOX-5 had a hydrolysis profile similar to those of the other FOX enzymes (Table 3) (4, 11, 16). Cephaloridine and cephalothin were hydrolyzed 70 to 80 times faster than penicillin. Hydrolysis of cefoxitin was 1,000-fold slower than cephaloridine hydrolysis. Notable among the FOX family of beta -lactamases is a low Km value of 0.9 µM for cefoxitin, which increased the catalytic efficiency (kcat/Km) for this substrate. Cefepime and cefpodoxime had low kcat values, but the catalytic efficiency of cefpodoxime was 10-fold higher than that for cefepime, primarily due to the low Km for cefpodoxime. Cefotaxime, ceftazidime, and aztreonam had hydrolysis rates too slow for reliable determination of kinetic parameters. Clavulanic acid and tazobactam were poor inhibitors, while aztreonam inhibited FOX-5 with a Ki of 1.6 nM (Table 3).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3.   Substrate and inhibitor profiles of purified FOX-5 beta -lactamase

Plasmid-mediated AmpC enzymes have been reported with increasing frequency in several U.S. medical centers (8;G. A. Jacoby, P. Han, M. Alvarez, and F. Tenover, Abstr. 35th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C40, 1995). In one study, the occurrence of AmpC-type beta -lactamases in clinical isolates of E coli, K. pneumoniae, and Proteus mirabilis was 1.2%, with half of these strains carrying the AmpC on a plasmid (8). This report is the first biochemical characterization of a FOX family plasmid-mediated beta -lactamase in the United States, indicating the expansion of this family of enzymes into North America. The association of FOX-5 with an insertion element suggests a mechanism for its incorporation into the K. pneumoniae p5064 plasmid. As a result, further transmission of FOX beta -lactamases may be expected.

Nucleotide sequence accession number. The GenBank accession number for the FOX-5 sequence is AY007369.


    ACKNOWLEDGMENTS

We thank Nancy Hanson for sharing the amino acid sequence of her plasmid-mediated FOX beta -lactamase before publication.


    FOOTNOTES

* Corresponding author. Mailing address: The R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869. Phone: (908) 704-5515. Fax: (908) 707-3501. E-mail: aqueenan{at}prius.jnj.com.

dagger Present address: Aventis, Bridgewater, NJ 08807.


    REFERENCES
Top
Abstract
Text
References

1. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC beta -lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931[Abstract/Free Full Text].
2. Bauernfeind, A., I. Stemplinger, R. Jungwirth, R. Wilhelm, and Y. Chong. 1996. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta -lactamase genes. Antimicrob. Agents Chemother. 40:1926-1930[Abstract].
3. Bauernfeind, A., S. Wagner, R. Jungwirth, I. Schneider, and D. Meyer. 1997. A novel class C beta -lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob. Agents Chemother. 41:2041-2046[Abstract].
4. Bou, G., A. Oliver, M. Ojeda, C. Monzon, and J. Martinez-Beltran. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta -lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549-2553[Abstract/Free Full Text].
5. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta -lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569[Abstract].
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta -lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233[Medline].
7. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of beta -lactamases from Gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84[Free Full Text].
8. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC beta -lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38:1791-1796[Abstract/Free Full Text].
9. Dixon, M. 1972. The graphical determination of Km and Ki. Biochem. J. 129:197-202[Medline].
10. Fosberry, A. P., D. J. Payne, E. J. Lawlor, and J. E. Hodgson. 1994. Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta -lactamase gene in Escherichia coli BS. Antimicrob. Agents Chemother. 38:1182-1185[Abstract/Free Full Text].
11. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta -lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157[Abstract/Free Full Text].
12. Gustafson, C. E., S. Chu, and T. J. Trust. 1994. Mutagenesis of the paracrystalline surface protein array of Aeromonas salmonicida by endogenous insertion elements. J. Mol. Biol. 237:452-463[CrossRef][Medline].
13. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type beta -lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta -lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990[Abstract/Free Full Text].
14. Jaurin, B., and T. Grundstrom. 1981. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta -lactamases of the penicillinase type. Proc. Natl. Acad. Sci. 78:4897-4901[Abstract/Free Full Text].
15. Jones, R. N. 1998. Important and emerging beta -lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes. Diagn. Microbiol. Infect. Dis. 31:461-466[CrossRef][Medline].
16. Marchese, A., G. Arlet, G. C. Schito, P. H. Lagrange, and A. Philippon. 1998. Characterization of FOX-3, an AmpC-type plasmid-mediated beta -lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:464-467[Abstract/Free Full Text].
17. Matthew, M., and A. M. Harris. 1976. Identification of beta -lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J. Gen. Microbiol. 94:55-67[Abstract/Free Full Text].
18. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 5th ed. NCCLS Standards, vol. 20. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Nordmann, P. 1998. Trends in beta -lactam resistance among Enterobacteriaceae. Clin. Infect. Dis. 27:S100-S106.
20. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated beta -lactamase (MIR-1) conferring resistance to oxyimino- and alpha -methoxy beta -lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209[Abstract/Free Full Text].
21. Record, M. T., Jr., W. S. Reznikoff, M. L. Craig, K. L. McQuade, and P. J. Schlax. 1996. Escherichia coli RNA polymerase (Esigma 70), promoters, and the kinetics of the steps of transcription initiation, p. 792-821. In F. C. Neidhart, et al. (ed.), Escherichia coli and Salmonella, cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
22. Sykes, R. B., D. P. Bonner, K. Bush, and N. H. Georgopapadakou. 1982. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob. Agents Chemother. 21:85-92[Abstract/Free Full Text].
23. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of a novel plasmid-mediated beta -lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645-654[Abstract/Free Full Text].
24. Walsh, T. R., L. Hall, A. P. MacGowan, and P. M. Bennett. 1995. Sequence analysis of two chromosomally mediated inducible beta -lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase. J. Antimicrob. Chemother. 36:41-52[Abstract/Free Full Text].

Antimicrobial Agents and Chemotherapy, November 2001, p. 3189-3194, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3189-3194.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Zhu, L.-X., Zhang, Z.-W., Liang, D., Jiang, D., Wang, C., Du, N., Zhang, Q., Mitchelson, K., Cheng, J. (2007). Multiplex Asymmetric PCR-Based Oligonucleotide Microarray for Detection of Drug Resistance Genes Containing Single Mutations in Enterobacteriaceae. Antimicrob. Agents Chemother. 51: 3707-3713 [Abstract] [Full Text]  
  • Wachino, J.-i., Kurokawa, H., Suzuki, S., Yamane, K., Shibata, N., Kimura, K., Ike, Y., Arakawa, Y. (2006). Horizontal Transfer of blaCMY-Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50: 534-541 [Abstract] [Full Text]  
  • Pichardo, C., Rodriguez-Martinez, J. M., Pachon-Ibanez, M. E., Conejo, C., Ibanez-Martinez, J., Martinez-Martinez, L., Pachon, J., Pascual, A. (2005). Efficacy of Cefepime and Imipenem in Experimental Murine Pneumonia Caused by Porin-Deficient Klebsiella pneumoniae Producing CMY-2 {beta}-Lactamase. Antimicrob. Agents Chemother. 49: 3311-3316 [Abstract] [Full Text]  
  • Yagi, T., Wachino, J.-i., Kurokawa, H., Suzuki, S., Yamane, K., Doi, Y., Shibata, N., Kato, H., Shibayama, K., Arakawa, Y. (2005). Practical Methods Using Boronic Acid Compounds for Identification of Class C {beta}-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 43: 2551-2558 [Abstract] [Full Text]  
  • Reisbig, M. D., Hanson, N. D. (2004). Promoter Sequences Necessary for High-Level Expression of the Plasmid-Associated ampC {beta}-Lactamase Gene blaMIR-1. Antimicrob. Agents Chemother. 48: 4177-4182 [Abstract] [Full Text]  
  • Nasim, K., Elsayed, S., Pitout, J. D. D., Conly, J., Church, D. L., Gregson, D. B. (2004). New Method for Laboratory Detection of AmpC {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae. J. Clin. Microbiol. 42: 4799-4802 [Abstract] [Full Text]  
  • Alvarez, M., Tran, J. H., Chow, N., Jacoby, G. A. (2004). Epidemiology of Conjugative Plasmid-Mediated AmpC {beta}-Lactamases in the United States. Antimicrob. Agents Chemother. 48: 533-537 [Abstract] [Full Text]  
  • Queenan, A. M., Foleno, B., Gownley, C., Wira, E., Bush, K. (2004). Effects of Inoculum and {beta}-Lactamase Activity in AmpC- and Extended-Spectrum {beta}-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates Tested by Using NCCLS ESBL Methodology. J. Clin. Microbiol. 42: 269-275 [Abstract] [Full Text]  
  • Jacoby, G. A., Chow, N., Waites, K. B. (2003). Prevalence of Plasmid-Mediated Quinolone Resistance. Antimicrob. Agents Chemother. 47: 559-562 [Abstract] [Full Text]  
  • Coudron, P. E., Hanson, N. D., Climo, M. W. (2003). Occurrence of Extended-Spectrum and AmpC Beta-Lactamases in Bloodstream Isolates of Klebsiella pneumoniae: Isolates Harbor Plasmid-Mediated FOX-5 and ACT-1 AmpC Beta-Lactamases. J. Clin. Microbiol. 41: 772-777 [Abstract] [Full Text]  
  • Brinas, L., Zarazaga, M., Saenz, Y., Ruiz-Larrea, F., Torres, C. (2002). {beta}-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals. Antimicrob. Agents Chemother. 46: 3156-3163 [Abstract] [Full Text]  
  • Doi, Y., Shibata, N., Shibayama, K., Kamachi, K., Kurokawa, H., Yokoyama, K., Yagi, T., Arakawa, Y. (2002). Characterization of a Novel Plasmid-Mediated Cephalosporinase (CMY-9) and Its Genetic Environment in an Escherichia coli Clinical Isolate. Antimicrob. Agents Chemother. 46: 2427-2434 [Abstract] [Full Text]  
  • Perez-Perez, F. J., Hanson, N. D. (2002). Detection of Plasmid-Mediated AmpC {beta}-Lactamase Genes in Clinical Isolates by Using Multiplex PCR. J. Clin. Microbiol. 40: 2153-2162 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Queenan, A. M.
Right arrow Articles by Bush, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Queenan, A. M.
Right arrow Articles by Bush, K.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»